Skip to main content
. 2023 Jun 13. Online ahead of print. doi: 10.1016/j.androl.2023.100366

Table 3.

Corpus cavernosum electromyography findings (VAD: Vasoactive-drug (Papaverine 60 mg.), SD: Standard deviation).

Group 1 (n = 9) Group 2 (n = 10) Group 3 (n = 10) p
Pre-VAD inj. amplitude, mean ± SD (μV) 233,33 ± 69,10 166,00 ± 43,25 255,00 ± 57,20 0,005*
Pre-VAD inj. frequency per min, mean ± SD 4,22 ± 0,36 3,70 ± 0,36 4,80 ± 0,41 0,162
Post-VAD inj. amplitude, mean ± SD (μV) 113,33 ± 25,00 123,00 ± 26,26 101,00 ± 23,23 0,150
Post-VAD inj. frequency per min, mean ± SD, 2,77 ± 0,22 2,60 ± 0,16 3,20 ± 0,32 0,344
Relaxation Degree, mean ± SD 0,41 ± 0,07 0,32 ± 0,06 0,58 ± 0,04 0,009**
*

Group1-Group2 p:0,042; Group1-Group3 p:0,690; Group2-Group3 p:0,005 (Mann Whitney U)

**

Group1-Group2 p:0,065; Group1-Group3 p:0,278; Group2-Group3 p:0,002 (Mann Whitney U)